New study sheds light on the best drug choices for some patients with advanced breast cancer 08 Oct 2020 Patients with metastatic breast cancer carrying a particular mutation fare better on one form of hormone therapy than another and can be identified using a blood test, according to a new study. Find out more Show/Hide
Major ‘plasmaMATCH’ trial uses blood test to match women with breast cancer to range of precision treatments 10 Sep 2020 A blood test that can identify a variety of mutations in advanced breast cancer can reliably match women to effective targeted treatments, early results of a major clinical trial reveal. Find out more Show/Hide
Breast cancer drug capivasertib enters major trial 24 Jun 2020 A major phase III trial of capivasertib, a cancer drug discovered following collaborative work between The Institute of Cancer Research, London, and partners, has begun in breast cancer. Find out more Show/Hide
ICR responds to NICE approval of palbociclib for treating advanced breast cancer after hormone therapy 28 Nov 2019
Personalised ‘liquid biopsy’ could detect return of breast cancer nearly eleven months earlier than hospital scans 01 Aug 2019
ESMO 2018: Major trial shows targeted drug – palbociclib – extends breast cancer survival 20 Oct 2018